Patient Count Queries Sample Clauses

Patient Count Queries. If the GPC Parties decide to allow Affiliate Investigators of External Institutions to perform automated Patient Count Queries, the Affiliate Investigator will be required to follow GPC policies and procedures, the External Institution must agree to be responsible for its Affiliate Investigators, and the External Institution must agree to execute any supplemental agreements that may be necessary to allow automated Patient Count Queries. Each GPC Party may decline to allow such automated Patient Count Queries.
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
Patient Count Queries. The Parties will work together to develop a process, to include the development of appropriate agreement(s) and procedures regarding system and data access, whereby a Participant may allow Data Requestors to directly perform Patient Count Queries using open-source software of a type to be determined (e.g., SHRINE) and configured by , which will be linked to the Participant’s Research Repository. Each Participant may decide whether or not to authorize such automated Patient Count Queries.
Sample 1
Patient Count Queries. The Parties will work together to develop a process, to include the development of appropriate agreement(s) and procedures regarding system and data access, whereby a Participant may allow Data Requestors to directly perform Patient Count Queries using open-source software of a type to be determined (e.g., SHRINE) and configured by KUMC, which will be linked to the Participant’s Research Repository. Each Participant may decide whether or not to authorize such automated Patient Count Queries. Feasibility Queries In addition to the process described in Section IV.2(d) above, the Parties will work together to develop a process, to include the development of appropriate agreement(s) and procedures regarding system and data access, whereby a Participant may allow Data Requestor to directly perform Feasibility Queries using open-source software of a type to be determined (e.g., SHRINE) and configured by KUMC, which will be linked to the Participant’s Research Repository. Each Participant may decide whether or not to authorize such automated Feasibility Queries.
Sample 1

Related to Patient Count Queries

  • Random Testing Notwithstanding any provisions of the Collective Agreement or any special agreements appended thereto, section 4.6 of the Canadian Model will not be applied by agreement. If applied to a worker dispatched by the Union, it will be applied or deemed to be applied unilaterally by the Employer. The Union retains the right to grieve the legality of any imposition of random testing in accordance with the Grievance Procedure set out in this Collective Agreement.

  • Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.

  • Review Protocol A narrative description of how the Claims Review was conducted and what was evaluated.

  • Patient Referrals Business Manager and Practice agree that the ----------------- benefits afforded either party hereunder are not payment for, and are not in any way contingent upon the referral, admission or any other arrangement for, the provision of any item or service offered by Business Manager or Practice.

  • Signaling protocol The Parties will interconnect their networks using SS7 signaling where Technically Feasible and available as defined in GR 905 Telcordia Standards including ISDN User Part (ISUP) for trunk signaling and TCAP for CCS-based features in the Interconnection of their networks. All Network Operations Forum (NOF) adopted standards shall be adhered to. Where available, CenturyLink signaling services to link its Signaling Transfer Points (STPs) for CLEC switches which connect to CenturyLink’s STPs via “A” links or for CLEC’s STPs to connect to CenturyLink’s STPs via “D” links which are dedicated to the transport of signaling for local Interconnection, may be ordered from the CenturyLink Tariff.

  • Patient Care Resident shall participate in safe, effective, and compassionate patient care, under supervision, commensurate with Resident's level of advancement and responsibility.

  • Drug Testing (A) The state and the PBA agree to drug testing of employees in accordance with section 112.0455, F.S., the Drug-Free Workplace Act.

  • Selection Criteria Each Contract is secured by a new or used Motorcycle. No Contract has a Contract Rate less than 1.00%. Each Contract amortizes the amount financed over an original term no greater than 84 months (excluding periods of deferral of first payment). Each Contract has a Principal Balance of at least $500.00 as of the Cutoff Date.

  • Tests and Preclinical and Clinical Trials The preclinical studies and clinical trials conducted by or, to the Company’s knowledge, on behalf of the Company, that are described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, as applicable, and are intended to be submitted to FDA or other comparable government entities, were and, if still ongoing, are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional scientific standards and all Authorizations and Applicable Laws, including, without limitation, the Federal Food, Drug and Cosmetic Act and the rules and regulations promulgated thereunder and for studies submitted to regulatory authorities for approval, current Good Clinical Practices and Good Laboratory Practices and any applicable rules and regulations of the jurisdiction in which such trials and studies are being conducted; the descriptions of the results of such studies and trials contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus are, to the Company’s knowledge, accurate and complete in all material respects and fairly present the data derived from such studies and trials; except to the extent disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company is not aware of any studies or trials, the results of which the Company believes reasonably call into question the study or trial results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus when viewed in the context in which such results are described and the clinical stage of development; and, except to the extent disclosed in the Registration Statement, the Pricing Disclosure Package or the Prospectus, the Company has not received any written notices or written correspondence from the FDA or any governmental entity requiring the termination or suspension of any preclinical studies or clinical trials conducted by or on behalf of the Company, other than ordinary course communications with respect to modifications in connection with the design and implementation of such trials, copies of which communications have been made available to you.

  • Contractor Hearing Board 1. If there is evidence that the Contractor may be subject to debarment, the Department will notify the Contractor in writing of the evidence which is the basis for the proposed debarment and will advise the Contractor of the scheduled date for a debarment hearing before the Contractor Hearing Board.

Time is Money Join Law Insider Premium to draft better contracts faster.